4-[(Z)-[5-(1-adamantyl)-6-(2-methoxyethoxymethoxy)-3-oxo-benzofuran-2-ylidene]methyl]benzoic acid

ID: ALA5287875

Chembl Id: CHEMBL5287875

Max Phase: Preclinical

Molecular Formula: C30H32O7

Molecular Weight: 504.58

Associated Items:

Names and Identifiers

Canonical SMILES:  COCCOCOc1cc2c(cc1C13CC4CC(CC(C4)C1)C3)C(=O)/C(=C/c1ccc(C(=O)O)cc1)O2

Standard InChI:  InChI=1S/C30H32O7/c1-34-6-7-35-17-36-26-13-25-23(12-24(26)30-14-19-8-20(15-30)10-21(9-19)16-30)28(31)27(37-25)11-18-2-4-22(5-3-18)29(32)33/h2-5,11-13,19-21H,6-10,14-17H2,1H3,(H,32,33)/b27-11-

Standard InChI Key:  OXEQXIOGHJWWJA-BCHBDCPOSA-N

Alternative Forms

  1. Parent:

    ALA5287875

    ---

Associated Targets(Human)

RARA Tclin Retinoic acid receptor alpha (1324 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 504.58Molecular Weight (Monoisotopic): 504.2148AlogP: 5.47#Rotatable Bonds: 9
Polar Surface Area: 91.29Molecular Species: ACIDHBA: 6HBD: 1
#RO5 Violations: 2HBA (Lipinski): 7HBD (Lipinski): 1#RO5 Violations (Lipinski): 2
CX Acidic pKa: 4.03CX Basic pKa: CX LogP: 5.07CX LogD: 1.93
Aromatic Rings: 2Heavy Atoms: 37QED Weighted: 0.28Np Likeness Score: 0.07

References

1. Lazinski LM, Royal G, Robin M, Maresca M, Haudecoeur R..  (2022)  Bioactive Aurones, Indanones, and Other Hemiindigoid Scaffolds: Medicinal Chemistry and Photopharmacology Perspectives.,  65  (19.0): [PMID:36126323] [10.1021/acs.jmedchem.2c01150]

Source